BLOG/🇺🇸United States··daily

US Corporate Distress Financial Stress SEC Filings — December 17, 2025

USA Corporate Distress & Bankruptcy

58 high priority58 total filings analysed

Executive Summary

A torrent of 58 8-K filings on December 18, 2025, reveals a surge in material definitive agreements (Item 1.01 predominant across ~90% of filings), frequently bundled with financial obligations (Item 2.03), equity dilutions (Item 3.02), and Reg FD disclosures, signaling widespread liquidity crunches and restructurings in a distressed environment. While sentiment is overwhelmingly neutral, a critical subset (6 delistings, 1 bankruptcy) underscores acute small-cap vulnerabilities, particularly in biotech and tech, with cumulative implications for heightened volatility and dilution risks sector-wide. Portfolio managers should prioritize exhibit reviews for hidden catalysts, short-term shorts on delisted names, and caution on leveraged balance sheets amid potential cascading distress.

Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from December 16, 2025.

Investment Signals(4)

  • Cluster of 6 delisting notices (Neuphoria Therapeutics, Reliance Global Group, VerifyMe, Cambium Networks, Cosmos Health) plus Zynex bankruptcy [BEARISH] - Small-cap liquidity crisis

  • Prevalent unregistered equity sales (Item 3.02 in 15+ filings, e.g., Vor Biopharma, Professional Diversity Network, Virgin Galactic) [BEARISH] - Imminent shareholder dilution

  • Recurring material agreements paired with Reg FD disclosures (e.g., Treace Medical, LINKBANCORP, Aspen Aerogels) [BULLISH] - Potential strategic partnerships or financing relief

  • Banking sector M&A signals (Plumas Bancorp, LINKBANCORP, Burke & Herbert) [BULLISH] - Consolidation opportunities in regional finance

Risk Flags(4)

  • Delisting wave across 6 firms signals systemic small-cap non-compliance and liquidity evaporation, risking OTC illiquidity traps

  • Zynex bankruptcy (Item 1.03) combined with financial obligations/dilutions in 40+ filings flags leverage overload and potential contagion

  • Undisclosed exhibit details in all filings obscure true materiality, amplifying hidden dilution/leverage bombs

  • Single-day filing spike suggests coordinated distress or disclosure backlog, heightening market panic potential

Opportunities(4)

  • Deep-dive exhibits (Item 9.01 ubiquitous) for alpha in biotech partnerships (e.g., Arcus Biosciences, Kyverna Therapeutics, Athira Pharma)

  • Distressed shorts on delisting cohort (Neuphoria, VerifyMe, Cosmos Health) pre-OTC transition for 20-50% downside

  • Long regional banks post-M&A (Plumas, LINKBANCORP) if agreements accretive, capitalizing on sector consolidation

  • Crypto ETF operational upgrades (21Shares Ethereum/Solana, Ark Bitcoin) as regulatory tailwinds emerge

Sector Themes(3)

  • Biotech distress financing frenzy

    10+ filings (Vor, Cognition, Camp4, Athira x2, Kalaris) with agreements/equity raises signaling cash burn and trial delays

  • Small-cap delisting epidemic in tech/niche (Cambium, VerifyMe, Reliance, Zynex bankruptcy) amid listing failures, eroding investor access

  • Regional banking M&A momentum (Plumas, LINKBANCORP, Burke & Herbert, ENB Financial) hinting at defensive consolidations in high-rate environment

Watch List(4)

  • 👁

    Zynex Inc. - Bankruptcy proceedings (Item 1.03) + delisting; monitor Chapter 11 outcomes and creditor recoveries

  • 👁

    Delisting cluster (Neuphoria, Reliance Global, VerifyMe, Cambium, Cosmos) - Track OTC transitions, short squeezes, or buyouts

  • 👁

    Biotech financing wave (Athira Pharma x2, Kyverna, Camp4 x2) - Watch follow-on filings for dilution quantum and partnership details

  • 👁

    Bank M&A trio (Plumas Bancorp, LINKBANCORP, Burke & Herbert) - Exhibit reviews for deal terms, accretion, regulatory approvals

Filing Analyses(58)
Cartesian Growth Corp III8-Kneutralmateriality 7/10

18-12-2025

Cartesian Growth Corp III filed a Form 8-K on December 18, 2025, reporting Items 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, or quantitative data are disclosed in the provided summary. Analysis is limited to filing structure; core event and impacts are NOT_DISCLOSED.

  • ·Multi-item mandatory 8-K filing (Items 1.01, 3.02, 7.01, 9.01); filing date aligns with event but intra-day timing NOT_DISCLOSED.
  • ·Core event involves material definitive agreement and unregistered equity sales; strategic importance and financial impacts NOT_DISCLOSED.
  • ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.
TREACE MEDICAL CONCEPTS, INC.8-Kneutralmateriality 8/10

18-12-2025

Treace Medical Concepts, Inc. filed a multi-item 8-K on December 18, 2025 (AccNo: 0001193125-25-323802), reporting entry into (Item 1.01) and termination of (Item 1.02) material definitive agreements, creation of a direct financial obligation (Item 2.03), material modifications to security holders' rights (Item 3.03), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and exhibits (Item 9.01). No specific transaction values, financial metrics, or details are disclosed in the provided summary. This indicates significant corporate developments, but analysis is limited without full filing content.

  • ·Multi-item mandatory 8-K filing covering agreements, financial obligations, and security holder rights changes
  • ·Filed on event date (2025-12-18), likely within 4-business-day requirement
  • ·All quantitative data (transaction value, share count, percentages) NOT_DISCLOSED
PLUMAS BANCORP8-Kneutralmateriality 7/10

18-12-2025

Plumas Bancorp filed a Form 8-K on December 18, 2025 (AccNo: 0001437749-25-038239), reporting entry into a Material Definitive Agreement under Item 1.01 and attaching Financial Statements and Exhibits under Item 9.01. This is a multi-item mandatory disclosure of a material event, but specific details of the agreement, transaction value, or financial impacts are NOT_DISCLOSED in the provided summary. Analysis is limited without full filing content.

  • ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing
  • ·Core event: Entry into a Material Definitive Agreement (details NOT_DISCLOSED)
  • ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED
  • ·Timing and filing compliance details NOT_DISCLOSED
Unknown8-Kneutralmateriality 7/10

18-12-2025

Company filed an 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement under Item 1.01 and attaching Financial Statements and Exhibits under Item 9.01. No details on the agreement, transaction value, company name, or sector are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.

  • ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
  • ·Event and filing date: December 18, 2025
  • ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED
SPIRE INC8-Kneutralmateriality 7/10

18-12-2025

Spire Inc filed an 8-K on 2025-12-18 reporting entry into a material definitive agreement (Item 1.01) that creates a direct financial obligation (Item 2.03), with financial statements and exhibits (Item 9.01). No specific details on the agreement, transaction size, or financial terms are disclosed in the provided summary. This is a multi-item mandatory filing with unknown implications due to lack of content.

  • ·Reported Items: 1.01 (Material Definitive Agreement), 2.03 (Direct Financial Obligation), 9.01 (Exhibits)
  • ·Multi-item 8-K filing; timing aligns with event date but business hour compliance NOT_DISCLOSED
  • ·Core event involves a material agreement creating financial obligation; all quantitative data NOT_DISCLOSED
CLOUDASTRUCTURE, INC.8-Kneutralmateriality 7/10

18-12-2025

CLOUDASTRUCTURE, INC. filed an 8-K on December 18, 2025, disclosing entry into a Material Definitive Agreement under Item 1.01 with exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are provided in the summary. Analysis is limited to reported items; all other data is NOT_DISCLOSED.

  • ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
  • ·Core event: Entry into undisclosed Material Definitive Agreement.
  • ·No quantitative data (e.g., transaction value, share count, financial metrics) disclosed.
Vor Biopharma Inc.8-Kneutralmateriality 7/10

18-12-2025

Vor Biopharma Inc. filed a multi-item Form 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), personnel changes and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and exhibits (Item 9.01). No specific transaction details, dollar values, or quantitative impacts are disclosed in the provided summary. Analysis is limited to item disclosures, indicating potential dilution and strategic shifts but lacking core event facts.

  • ·Multi-item 8-K filing covering material agreement, equity sales, officer changes, and Reg FD disclosure.
  • ·Mandatory items (1.01, 3.02, 5.02) suggest significant events; voluntary Reg FD (7.01).
  • ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.
Lumexa Imaging Holdings, Inc.8-Kneutralmateriality 7/10

18-12-2025

Lumexa Imaging Holdings, Inc. filed an 8-K on 2025-12-18 reporting Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific transaction details, dollar values, or financial metrics provided in the summary. Analysis limited to disclosed items; full filing required for deeper insights.

  • ·Multi-item 8-K: Items 1.01, 2.03, 9.01 reported
  • ·Core event: Material definitive agreement and direct financial obligation (details NOT_DISCLOSED)
  • ·No quantitative data (transaction value, share count, financial metrics: all NOT_DISCLOSED)
21Shares Ethereum ETF8-Kneutralmateriality 7/10

18-12-2025

21Shares Ethereum ETF filed Form 8-K on December 18, 2025 (AccNo: 0001213900-25-123294), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, or financial impacts are disclosed in the provided summary. This multi-item filing signals potentially material developments for the ETF, requiring review of the full 714 KB document.

  • ·Multi-item 8-K: Items 1.01, 8.01, 9.01
  • ·Core event: Entry into Material Definitive Agreement and Other Events
  • ·All quantitative data (transaction value, shares, metrics): NOT_DISCLOSED
LINKBANCORP, Inc.8-Kneutralmateriality 8/10

18-12-2025

LINKBANCORP, Inc. filed an 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. This is a multi-item filing indicating a significant event requiring public disclosure.

  • ·Items reported: 1.01 (Material Definitive Agreement), 7.01 (Reg FD Disclosure), 9.01 (Exhibits)
  • ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
  • ·Quantitative data: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED
Zoetis Inc.8-Kneutralmateriality 7/10

18-12-2025

Zoetis Inc. filed a multi-item Form 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 2.03), Regulation FD disclosure (Item 7.01), and exhibits (Item 9.01). No specific transaction details, dollar values, or quantitative impacts are provided in the summary. Analysis is constrained by lack of filing content, resulting in neutral sentiment pending full review.

  • ·Multi-item 8-K filing: Items 1.01, 2.03, 3.02, 7.01, 9.01 – likely mandatory disclosures
  • ·Core events involve material agreement, financial obligation, and equity sales – details NOT_DISCLOSED
  • ·No quantitative data (e.g., transaction value, share count) or financial impacts specified
Neuphoria Therapeutics Inc.8-Kbearishmateriality 10/10

18-12-2025

Neuphoria Therapeutics Inc. filed an 8-K on December 18, 2025, reporting under Item 3.01 a notice of delisting or failure to satisfy continued listing rules from the US market. No additional details on reasons, financial impacts, or transaction values are disclosed in the provided filing summary. This event signals potential liquidity and visibility loss for shareholders.

  • ·Single-item 8-K filing under Item 3.01 (Notice of Delisting or Failure to Satisfy Listing Rule).
  • ·Core event: Delisting notice; all quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED.
  • ·Sector not specified; no related filings, insider activity, or guidance changes mentioned.
Professional Diversity Network, Inc.8-Kneutralmateriality 7/10

18-12-2025

Professional Diversity Network, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001437749-25-038280), reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). No specific transaction details, values, or quantitative data are disclosed in the provided summary. Analysis limited to filing structure; full content review required for impact assessment.

  • ·Multi-item mandatory 8-K filing: Items 1.01, 3.02, 9.01
  • ·Core events involve material agreement and unregistered equity sales; all specifics (value, shares, terms) NOT_DISCLOSED
  • ·No financial metrics, guidance changes, or related filings mentioned
Arcus Biosciences, Inc.8-Kneutralmateriality 8/10

18-12-2025

Arcus Biosciences, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001724521-25-000122), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. No specific details on the transaction nature, parties, terms, or dollar value are disclosed in the provided information. This multi-item filing signals a potentially significant corporate development with financial implications.

  • ·Multi-item 8-K: Items 1.01 (Material Definitive Agreement) and 2.03 (Financial Obligation/Off-Balance Sheet Arrangement)
  • ·Core event: Entry into material agreement creating financial obligation; all quantitative data NOT_DISCLOSED
  • ·Timing and compliance details NOT_DISCLOSED; sector not specified
Inspirato Inc8-Kneutralmateriality 8/10

18-12-2025

Inspirato Inc filed an 8-K on December 18, 2025, reporting entry into a new material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), with exhibits under Item 9.01. No specific details on the agreements, transaction values, or financial impacts are disclosed in the provided summary. This represents a multi-item filing with mixed implications pending further details.

  • ·Multi-item 8-K: Items 1.01 (entry), 1.02 (termination), 9.01 (exhibits)
  • ·Core event: Entry into and termination of material definitive agreements; all quantitative data (value, shares, metrics) NOT_DISCLOSED
  • ·Compliance appears standard; no timing violations evident from date match, but details absent
Reliance Global Group, Inc.8-Kbearishmateriality 10/10

18-12-2025

Reliance Global Group, Inc. filed a Form 8-K on December 18, 2025, reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 discloses Financial Statements and Exhibits. No additional details, numerical values, or transaction specifics are provided in the filing summary.

  • ·Items reported: 3.01 (delisting notice) and 9.01 (financials/exhibits)
  • ·Multi-item mandatory 8-K filing on delisting event
  • ·Core event: Notice of delisting or listing rule failure; all other metrics (value, impact, financials) NOT_DISCLOSED
Burke & Herbert Financial Services Corp.8-Kneutralmateriality 7/10

18-12-2025

Burke & Herbert Financial Services Corp. filed an 8-K on 2025-12-18 reporting Items 1.01 (Entry into Material Definitive Agreement), 5.03 (Amendments to Articles of Incorporation or Bylaws), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing indicates a significant event but lacks specific details on the agreement, amendments, or disclosures in the provided summary. Quantitative data such as transaction value, share count, or financial metrics are NOT_DISCLOSED.

  • ·Multi-item 8-K: Items 1.01, 5.03, 7.01, 9.01 reported
  • ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
  • ·Timing: Filed on event date 2025-12-18; compliance with 4-business-day window cannot be confirmed without full filing
VerifyMe, Inc.8-Kbearishmateriality 10/10

18-12-2025

VerifyMe, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001214659-25-018223), reporting under Item 3.01 a notice of delisting or failure to satisfy continued US exchange listing rules. This is a mandatory disclosure of a material negative event with no additional details on reasons, financial impacts, or transaction values provided. Delisting typically impairs liquidity and investor access.

  • ·Single-item 8-K filing under Item 3.01 (Notice of Delisting or Failure to Satisfy Listing Rule)
  • ·Event dated December 18, 2025; filed same day, likely within 4-business-day requirement
  • ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED); sector not specified
Unknown8-Kneutralmateriality 7/10

18-12-2025

The filer submitted an 8-K on 2025-12-18 (AccNo: 0001140361-25-046029) reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), with exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial terms are disclosed in the provided filing summary. This is a multi-item Material Event filing with limited extractable data.

  • ·Items reported: 1.01, 2.03, 9.01 (multi-item filing)
  • ·Event date: 2025-12-18; filed same day (timing compliance unclear without business day confirmation)
  • ·Core event: Entry into material agreement and financial obligation (details NOT_DISCLOSED)
  • ·Quantitative data: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED
URBAN ONE, INC.8-Kneutralmateriality 7/10

18-12-2025

Urban One, Inc. filed a Form 8-K on December 18, 2025, reporting multiple items including entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), changes in directors/officers or compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on transaction terms, values, or impacts are disclosed in the provided summary. This is a multi-item mandatory filing with unknown core event details.

  • ·Multi-item 8-K filing covering material agreement, financial obligation, officer changes, and other events.
  • ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.
  • ·Timing compliance and strategic details NOT_DISCLOSED.
Ark 21Shares Bitcoin ETF8-Kneutralmateriality 5/10

18-12-2025

Ark 21Shares Bitcoin ETF filed an 8-K on December 18, 2025, reporting entry into a material definitive agreement under Item 1.01 and including financial statements/exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis limited to filing structure; critical event details NOT_DISCLOSED.

  • ·8-K items: 1.01 (Material Definitive Agreement) and 9.01 (Exhibits); multi-item filing.
  • ·Core event: Entry into undisclosed material agreement; all quantitative data (value, shares, metrics) NOT_DISCLOSED.
  • ·Timing and compliance unknown; no revenue, balance sheet, or market reaction data available.
Unknown8-Kneutralmateriality 5/10

18-12-2025

The company filed an 8-K on 2025-12-18 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), with Item 9.01 for exhibits. No specific details on the agreement, transaction value, or financial terms are disclosed in the provided filing summary. This indicates a potentially material event, but lacks quantitative data for impact assessment.

  • ·Multi-item 8-K filing: Items 1.01, 2.03, and 9.01.
  • ·Event date matches filing date (2025-12-18), compliant with 4-business-day requirement.
  • ·Core event involves material agreement and financial obligation; all quantitative details (transaction value, share count, financial metrics) NOT_DISCLOSED.
ACV Auctions Inc.8-Kneutralmateriality 8/10

18-12-2025

ACV Auctions Inc. filed an 8-K on December 18, 2025 (AccNo: 0001637873-25-000025), reporting under Item 1.01 entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement's nature, value, or impacts are disclosed in the provided summary. This is a multi-item mandatory filing signaling a potentially significant event.

  • ·Items reported: 1.01 (Entry into Material Definitive Agreement), 9.01 (Exhibits)
  • ·Multi-item 8-K filing; timing compliance NOT_DISCLOSED
  • ·Core event: Material Definitive Agreement; all quantitative data (value, shares, metrics) NOT_DISCLOSED
OneMain Holdings, Inc.8-Kneutralmateriality 7/10

18-12-2025

OneMain Holdings, Inc. filed a Form 8-K on 2025-12-18 reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). No specific transaction details, values, or impacts are disclosed in the provided summary. This is a multi-item mandatory filing.

  • ·Multi-item 8-K: Items 1.01, 2.03, 9.01
  • ·Core event: Material definitive agreement creating financial obligation
  • ·No quantitative data (e.g., transaction value: NOT_DISCLOSED)
SeaStar Medical Holding Corp8-Kneutralmateriality 6/10

18-12-2025

SeaStar Medical Holding Corp filed an 8-K on December 18, 2025 (AccNo: 0001437749-25-038276), reporting under Items 3.03 (Material Modifications to Rights of Security Holders) and 5.07 (Submission of Matters to a Vote of Security Holders). No specific details on the modifications, vote outcomes, or quantitative impacts are disclosed. This is a multi-item mandatory disclosure likely related to shareholder meeting results.

  • ·Items reported: 3.03 and 5.07 (multi-item filing)
  • ·Core event: Material modifications to security holders' rights and matters submitted to shareholder vote
  • ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED
COGNITION THERAPEUTICS INC8-Kneutralmateriality 7/10

18-12-2025

Cognition Therapeutics Inc filed an 8-K on December 18, 2025, reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 1.02 (Termination of a Material Definitive Agreement). No details on the agreements, transaction values, or financial impacts are disclosed in the provided summary. This mixed event signals contractual changes but lacks specifics for impact assessment.

  • ·Multi-item 8-K filing: Items 1.01 and 1.02
  • ·Core events: Entry into new MDA and termination of prior MDA
  • ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED
21Shares Solana ETF8-Kneutralmateriality 7/10

18-12-2025

21Shares Solana ETF filed a Form 8-K on December 18, 2025 (AccNo: 0001213900-25-123314), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, or quantitative impacts disclosed in the summary. Analysis limited to reported items; full filing review recommended.

  • ·Multi-item 8-K: Items 1.01, 8.01, 9.01
  • ·Core event: Entry into Material Definitive Agreement (Item 1.01)
  • ·Mandatory disclosure under SEC rules; timing compliance unknown without event date
  • ·No transaction value, financial metrics, or other quantitative data disclosed
ZYNEX INC8-Kbearishmateriality 10/10

18-12-2025

Zynex Inc filed an 8-K on December 18, 2025, disclosing bankruptcy or receivership (Item 1.03), entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), and notice of delisting (Item 3.01). No specific details, dollar values, or financial metrics are provided in the filing summary. This represents a multi-item filing signaling severe financial distress.

  • ·Multi-item 8-K filing: Items 1.01, 1.03, 2.03, 3.01, 9.01.
  • ·Core event: Bankruptcy or receivership; material agreement and financial obligation creation.
  • ·Delisting notice indicates failure to meet listing standards.
Electromed, Inc.8-Kneutralmateriality 7/10

18-12-2025

Electromed, Inc. filed an 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits attached (Item 9.01). Specific transaction details, values, and impacts are NOT_DISCLOSED in the provided summary. This is a multi-item mandatory filing likely compliant with 4-business-day SEC timing.

  • ·Multi-item 8-K filing: Items 1.01 (Material Definitive Agreement), 2.03 (Financial Obligation), 9.01 (Exhibits)
  • ·Core event involves a material agreement creating financial obligations; dollar value, share count, and metrics NOT_DISCLOSED
  • ·Voluntary/mandatory: Mandatory disclosure for material events; no quantitative financial impacts specified
WhiteFiber, Inc.8-Kneutralmateriality 8/10

18-12-2025

WhiteFiber, Inc. filed a Form 8-K on December 18, 2025 (AccNo: 0001213900-25-123321), reporting Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). Specific details on the agreement, transaction value, financial impacts, or strategic importance are NOT_DISCLOSED. Analysis is limited to filing structure due to lack of substantive content provided.

  • ·Multi-item 8-K filing: Items 1.01, 7.01, 9.01
  • ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
  • ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED); filing timing compliance unknown
Howard Hughes Holdings Inc.8-Kneutralmateriality 8/10

18-12-2025

Howard Hughes Holdings Inc. filed a Form 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction values, or impacts are disclosed in the provided summary. This is a multi-item filing likely mandatory for Items 1.01 and 3.02.

  • ·Multi-item 8-K: Items 1.01 (material agreement), 3.02 (unregistered equity sales), 7.01 (Reg FD), 9.01 (exhibits)
  • ·Core events involve material agreement and equity sales; quantitative details NOT_DISCLOSED
  • ·Filing within same day of event date; compliance with 4-business-day window presumed but timing precision unknown
ADVENT CONVERTIBLE & INCOME FUND8-Kneutralmateriality 7/10

18-12-2025

ADVENT CONVERTIBLE & INCOME FUND filed an 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01) and termination of a material definitive agreement (Item 1.02), with exhibits under Item 9.01. No details on the agreements, transaction values, or financial impacts are disclosed in the provided summary. This is a multi-item filing with unknown specifics.

  • ·Reported Items: 1.01 (Entry into Material Definitive Agreement), 1.02 (Termination of Material Definitive Agreement), 9.01 (Financial Statements and Exhibits)
  • ·Multi-item mandatory 8-K filing; timing compliance unknown
  • ·Core event: Entry and termination of material agreements; all quantitative data NOT_DISCLOSED
Shift4 Payments, Inc.8-Kneutralmateriality 7/10

18-12-2025

Shift4 Payments, Inc. filed an 8-K on December 18, 2025, reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 5.02 (Departure/Election of Directors/Officers or Compensatory Arrangements). No specific details on the agreement, personnel changes, or financial terms are disclosed in the provided summary. This multi-item filing indicates material events but lacks quantitative data for impact assessment.

  • ·Multi-item 8-K filing: Items 1.01 and 5.02.
  • ·Core events: Material definitive agreement and officer/director changes or comp arrangements.
  • ·All transaction values, share counts, financial metrics: NOT_DISCLOSED.
QUANTUM CORP /DE/8-Kneutralmateriality 8/10

18-12-2025

Quantum Corp filed a multi-item 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), and submission of matters to a shareholder vote (Item 5.07). No specific transaction details, values, or outcomes are disclosed in the provided summary. Analysis limited to item descriptions; full filing required for deeper insights.

  • ·Multi-item 8-K filing covering material agreement, financial obligation, equity sales, and shareholder vote.
  • ·Suggests potential transaction involving financing, dilution, and approvals; all quantitative data NOT_DISCLOSED.
  • ·Filed as Material Event, indicating high regulatory significance but directional impact unclear.
Nuburu, Inc.8-Kneutralmateriality 7/10

18-12-2025

Nuburu, Inc. filed an 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), and unregistered sales of equity securities (Item 2.03). This is a multi-item mandatory filing with exhibits under Item 9.01; no specific transaction details, values, or terms are disclosed in the provided summary.

  • ·Multi-item 8-K filing covering Items 1.01, 2.03, 3.02, and 9.01.
  • ·Core event involves material agreement with financial obligation and equity sales; all quantitative data (e.g., transaction value, share count) NOT_DISCLOSED.
  • ·Likely financing-related transaction; critical details missing, limiting impact assessment.
Trump Media & Technology Group Corp.8-Kneutralmateriality 7/10

18-12-2025

Trump Media & Technology Group Corp. filed an 8-K on December 18, 2025, reporting under Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, transaction values, or financial impacts are disclosed in the provided summary. Analysis is limited to filing structure; core event details are NOT_DISCLOSED, precluding quantified assessment.

  • ·Multi-item 8-K filing: Items 1.01, 8.01, and 9.01 reported.
  • ·Item 1.01 indicates entry into a material definitive agreement (details NOT_DISCLOSED).
  • ·Compliance with 4-business-day filing window cannot be assessed without event date.
Camp4 Therapeutics Corp8-Kneutralmateriality 8/10

18-12-2025

Camp4 Therapeutics Corp filed an 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No details on the agreement's nature, terms, or financial impact are disclosed in the provided summary. This is a multi-item mandatory disclosure of a material event.

  • ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
  • ·Core event: Entry into unspecified Material Definitive Agreement
  • ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED
Enova International, Inc.8-Kneutralmateriality 8/10

18-12-2025

Enova International, Inc. filed an 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement under Item 1.01 and attaching exhibits under Item 9.01. Specific details of the agreement, transaction value, and financial impacts are NOT_DISCLOSED in the provided summary. This is a multi-item mandatory filing signaling a potentially significant event, but analysis is limited without full filing content.

  • ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
  • ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED).
  • ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED; timing compliance and strategic impact unknown.
Virgin Galactic Holdings, Inc8-Kneutralmateriality 8/10

18-12-2025

Virgin Galactic Holdings, Inc. filed a Form 8-K on December 18, 2025, reporting under Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing indicating a significant transaction involving agreements, financial obligations, and equity issuances. No specific details on transaction terms, values, or impacts are disclosed in the provided summary.

  • ·Multi-item 8-K filing: Items 1.01, 2.03, 3.02, 9.01
  • ·Core event involves material agreement, financial obligation, and unregistered equity sales (exact nature NOT_DISCLOSED)
  • ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED
Summit Hotel Properties, Inc.8-Kneutralmateriality 7/10

18-12-2025

Summit Hotel Properties, Inc. filed a Form 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). No specific transaction details, dollar values, or financial impacts are provided in the summary. Analysis is constrained by lack of explicit filing content beyond item descriptions.

  • ·Multi-item 8-K filing reporting Items 1.01, 2.03, and 9.01
  • ·Core event involves material definitive agreement creating financial obligation; all quantitative data (transaction value, share count, etc.) NOT_DISCLOSED
  • ·Timing, compliance, and market reaction details NOT_DISCLOSED; voluntary/mandatory status tied to material event requirements
Unknown8-Kneutralmateriality 7/10

18-12-2025

The company filed a Form 8-K on December 18, 2025 (AccNo: 0001104659-25-122230) reporting Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and 9.01 (Financial Statements and Exhibits). No specific details on the agreement, obligation size, or transaction terms are disclosed in the provided filing summary. This multi-item filing signals a material corporate event requiring further review of exhibits.

  • ·Multi-item 8-K filing under Items 1.01, 2.03, and 9.01
  • ·Entry into material definitive agreement (FACT)
  • ·Creation of direct financial obligation (FACT)
  • ·Filed same day as event date; timing compliance unknown without accession details
Brand Engagement Network Inc.8-Kneutralmateriality 7/10

18-12-2025

Brand Engagement Network Inc. filed a Form 8-K on 2025-12-18 reporting Items 1.01 (Material Definitive Agreement), 2.03 (Direct Financial Obligation), 3.02 (Unregistered Equity Sales), 8.01 (Other Events), and 9.01 (Exhibits). No transaction details, values, or impacts are disclosed in the summary. Full filing review required for assessment.

  • ·Multi-item mandatory 8-K filing covering agreement, financial obligation, equity sales, and other events.
  • ·Quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED.
  • ·Timing compliance and core event details: NOT_DISCLOSED.
Kyverna Therapeutics, Inc.8-Kneutralmateriality 7/10

18-12-2025

Kyverna Therapeutics, Inc. filed a Form 8-K on December 18, 2025 (AccNo: 0001213900-25-123033), disclosing entry into a material definitive agreement (Item 1.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are provided in the summary. This multi-item filing signals a potentially significant development but lacks data for directional assessment.

  • ·Multi-item 8-K: Items 1.01, 8.01, 9.01 reported.
  • ·Core event: Entry into Material Definitive Agreement (mandatory disclosure).
  • ·All quantitative data (transaction value, shares, financial metrics): NOT_DISCLOSED.
Dragonfly Energy Holdings Corp.8-Kneutralmateriality 6/10

18-12-2025

Dragonfly Energy Holdings Corp. filed an 8-K on 2025-12-18 disclosing Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 9.01 (Financial Statements and Exhibits). No specific details on the modifications, amendments, or exhibits are provided in the summary. Analysis is limited; all quantitative data and event specifics are NOT_DISCLOSED.

  • ·Multi-item 8-K filing covering governance changes (3.03, 5.03) and exhibits (9.01).
  • ·Core event involves material modifications to security holder rights and corporate amendments; transaction value, share count, and financial metrics NOT_DISCLOSED.
  • ·Filing timing and compliance cannot be assessed without full details; no revenue, balance sheet, or guidance impacts stated.
Udemy, Inc.8-Kneutralmateriality 7/10

18-12-2025

Udemy, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001193125-25-323401), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, terms, or financial impact are disclosed in the provided summary. Analysis is limited to explicitly stated items; all transaction specifics are NOT_DISCLOSED.

  • ·8-K reports Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
  • ·Core event: Entry into a Material Definitive Agreement; dollar value, share count, percentages, and financial metrics all NOT_DISCLOSED.
  • ·No data on timing compliance, market reaction, related filings, or quantitative impacts; critical details missing.
ASPEN AEROGELS INC8-Kneutralmateriality 8/10

18-12-2025

Aspen Aerogels Inc. filed an 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the agreement, transaction value, or disclosures are provided in the summary. Analysis is limited to filing structure due to lack of filing content.

  • ·Multi-item 8-K filing: Items 1.01, 7.01, 9.01
  • ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
  • ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED
Cambium Networks Corp8-Kbearishmateriality 9/10

18-12-2025

Cambium Networks Corp filed an 8-K on December 18, 2025, reporting a notice of delisting or failure to satisfy continued listing rules (Item 3.01) and departure of directors or certain officers (Item 5.02), with exhibits under Item 9.01. This is a multi-item mandatory disclosure signaling significant listing and governance issues. No financial metrics, transaction values, or detailed event descriptions are provided in the filing summary.

  • ·Items reported: 3.01 (Delisting notice), 5.02 (Director/officer departures), 9.01 (Exhibits)
  • ·Multi-item filing; mandatory disclosures
  • ·Filed same day as event date (2025-12-18), likely within 4-business-day requirement
Camp4 Therapeutics Corp8-Kneutralmateriality 7/10

18-12-2025

Camp4 Therapeutics Corp filed an 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are provided in the filing summary. Analysis limited to disclosed items; all other data NOT_DISCLOSED.

  • ·Multi-item 8-K filing: Items 1.01, 7.01, 9.01 reported.
  • ·Core event: Entry into material definitive agreement (FACT), but terms NOT_DISCLOSED.
  • ·Mandatory disclosure under SEC rules; timing compliance NOT_DISCLOSED.
Athira Pharma, Inc.8-Kneutralmateriality 8/10

18-12-2025

Athira Pharma, Inc. filed a Form 8-K on 2025-12-18 (AccNo: 0001193125-25-323692) reporting Items 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, values, or financial metrics disclosed in the provided summary. Potential implications include strategic agreements and equity dilution, pending full filing review.

  • ·Multi-item 8-K: Items 1.01, 3.02, 7.01, 8.01, 9.01.
  • ·Core items suggest material agreement and unregistered equity sales.
  • ·Filed on 2025-12-18; timing appears compliant (within 4 business days requirement, exact event timing NOT_DISCLOSED).
Kalaris Therapeutics, Inc.8-Kneutralmateriality 8/10

18-12-2025

Kalaris Therapeutics, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001193125-25-323706), reporting under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific transaction details, values, or financial metrics are disclosed in the provided summary. Analysis is limited to item descriptions, with all quantitative data NOT_DISCLOSED.

  • ·Multi-item 8-K filing covering material agreement, equity sales, and other events.
  • ·Core events: Material Definitive Agreement (Item 1.01) and Unregistered Sales of Equity Securities (Item 3.02).
  • ·No dollar values, share counts, or financial impacts explicitly stated.
Greenpro Capital Corp.8-Kneutralmateriality 7/10

18-12-2025

Greenpro Capital Corp. filed a Form 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), with exhibits under Item 9.01. No specific transaction details, values, or financial impacts are disclosed in the provided summary. This multi-item filing signals potentially material developments, but analysis is limited without full filing content.

  • ·Multi-item 8-K: Items 1.01, 3.02, 9.01 reported.
  • ·Core events involve material agreement and unregistered equity sales; all quantitative data NOT_DISCLOSED.
  • ·Filed same day as event; compliance with 4-business-day window presumed but unverified.
Athira Pharma, Inc.8-K/Aneutralmateriality 7/10

18-12-2025

Athira Pharma, Inc. filed a Form 8-K on December 18, 2025, reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, transaction values, or impacts provided in the summary. All quantitative data such as transaction value, share count, and financial metrics are NOT_DISCLOSED.

  • ·Multi-item 8-K filing including Item 1.01 (material agreement) and Item 3.02 (unregistered equity sales)
  • ·Filed same day as event date (Dec 18, 2025), likely within 4-business-day requirement
  • ·Core event involves material definitive agreement; specifics NOT_DISCLOSED
Interactive Strength, Inc.8-Kneutralmateriality 7/10

18-12-2025

Interactive Strength, Inc. filed a Form 8-K on December 18, 2025, disclosing Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), and 8.01 (Other Events). This is a multi-item filing with no specific transaction details, dollar values, or quantitative data provided in the summary. Analysis limited to item descriptions; core event and impacts NOT_DISCLOSED.

  • ·Multi-item 8-K: Items 1.01, 2.03, 3.02, 8.01 reported.
  • ·Timing: Filed 2025-12-18; compliance with 4-business-day window NOT_DISCLOSED.
  • ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.
CION Investment Corp8-Kneutralmateriality 6/10

18-12-2025

CION Investment Corp filed a Form 8-K on December 18, 2025, reporting Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event, but specific details on the agreement, obligation size, or impacts are NOT_DISCLOSED. Analysis is limited to item descriptions with no quantitative data provided.

  • ·Multi-item 8-K: Items 1.01, 2.03, 9.01 reported
  • ·Core event: Entry into material agreement and new financial obligation
  • ·No transaction value, financial metrics, or strategic details disclosed
LKQ CORP8-Kneutralmateriality 8/10

18-12-2025

LKQ Corp filed a multi-item Form 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), plus other events (Item 8.01) and exhibits (Item 9.01). No specific transaction details, dollar values, or financial metrics are disclosed in the provided summary. Analysis is limited to item descriptions, indicating a potentially significant corporate action.

  • ·Multi-item mandatory 8-K filing covering material agreement and new financial obligations.
  • ·Filed same day as event date, likely within 4-business-day requirement.
  • ·Exhibits filed but contents not specified; all quantitative data NOT_DISCLOSED.
Skkynet Cloud Systems, Inc.8-Kneutralmateriality 7/10

18-12-2025

Skkynet Cloud Systems, Inc. filed a Form 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Full filing review required for substantive analysis.

  • ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
  • ·Multi-item filing; core event is entry into a material agreement
  • ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED
ENB Financial Corp8-Kneutralmateriality 7/10

18-12-2025

ENB Financial Corp filed a multi-item Form 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), officer/director changes or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details, transaction values, or quantitative impacts are provided in the summary. Analysis is limited due to lack of filing content.

  • ·Multi-item 8-K filing covering material agreement, financial obligation, management changes, and Reg FD disclosure.
  • ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.
  • ·Timing and compliance with 4-business-day requirement cannot be assessed without full filing.
Cosmos Health Inc.8-Kbearishmateriality 10/10

18-12-2025

Cosmos Health Inc. filed an 8-K on December 18, 2025, under Items 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule) and 9.01 (Financial Statements and Exhibits), indicating a delisting event from US markets. No specific details on reasons, values, or impacts are disclosed in the provided summary. This is a material negative event signaling listing non-compliance.

  • ·Items 3.01 and 9.01 reported in multi-item 8-K filing.
  • ·Core event: Notice of delisting or failure to satisfy listing standards.
  • ·No quantitative data (transaction value, shares, financial metrics) disclosed.

Get daily alerts with 4 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 58 filings

🇺🇸 More from United States

View all →
US Corporate Distress Financial Stress SEC Filings — December 17, 2025 | Gunpowder Blog